Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Brain cannabinoid systems as targets for the therapy of neurological disorders.
Neurobiology of disease·1999
AM630 is an inverse agonist at the human cannabinoid CB1 receptor.
Life sciences·1998
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.
European journal of pharmacology·1998
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.
European journal of pharmacology·1997
delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.
European journal of pharmacology·1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
European journal of pharmacology·1997
Complete coding sequence of Taiwan bat lyssavirus 2 from Chinese noctule (Nyctalus plancyi velutinus) at New Taipei City, Taiwan.
Microbiology resource announcements·2026
Brain fluorodeoxyglucose PET anatomical segmentation via AI: extensive validation in the neurodegenerative spectrum.
Brain : a journal of neurology·2026
Detection of intracerebral hemorrhage in putrefied pig brains using computed tomography, magnetic resonance imaging and a urine test strip.
Forensic science, medicine, and pathology·2026
Comparison of Expert Reads Versus Local Clinical Reads of Amyloid PET Scans in the IDEAS Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Development and Epitope Characterization of Monoclonal Antibodies Targeting the Rabies Virus P Protein.
Journal of medical virology·2026
Development and Humanization of a Camelid-Derived Neutralizing Nanobody Targeting Botulinum Neurotoxin Type A.
International journal of nanomedicine·2026